FDA Clearance Tracker · P900009-S044
Exogen Ultrasound Bone Healing System
Last checked: Nov 20, 2026Latest source record: Dec 20, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Dec 20, 2019
Approved
Time to decision
178 days
Received Jun 25, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class II
The decision
- FDA number
- P900009-S044
- Device name
- Exogen Ultrasound Bone Healing System
- Applicant
- Bioventus, LLC
- Applicant location
- Durham, NC
- Received
- Jun 25, 2019
- Decided
- Dec 20, 2019
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P900009
Device type
- Device type
- Stimulator, bone growth, non-invasive (LOF)
- Device class
- Class II
- Regulation
- 21 CFR 890.5870
- Specialty
- Orthopedic Surgery
FDA's approval statement
As written in FDA's record.
Approval for modified indications for use to include adjunctive use in patients with internal or external fracture fixation hardware present, patients undergoing treatment for infection at the fracture site, and patients believed to have diminished bone quality.
Source documents
Other decisions for Bioventus, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K253877 · Decided Aug 26, 2026 · 265 days after receipt
Device type: Stimulator, Peripheral Nerve, Implanted (Pain Relief) (GZF) · Neurology & Neurosurgery
K243782 · Decided Jul 16, 2025 · 219 days after receipt
Device type: Stimulator, Peripheral Nerve, Implanted (Pain Relief) (GZF) · Neurology & Neurosurgery
K243678 · Decided Jul 3, 2025 · 218 days after receipt
Device type: Stimulator, Peripheral Nerve, Implanted (Pain Relief) (GZF) · Neurology & Neurosurgery
4 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.